S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Merck KGaA: In Talks With Potential Partners to Develop Immuno-Oncology Drug (2014/9/18)|
|Germany's Merck to Buy Sigma-Aldrich for $17 Billion--3rd Update (2014/9/22)|
|Germany's Merck to Buy Sigma-Aldrich for $17 Billion--2nd Update (2014/9/22)|
|Germany's Merck to Buy Sigma-Aldrich for $17 Billion--Update (2014/9/22)|
|Merck to End Clinical Development of Lung Cancer Drug Tecemotide (2014/9/12)|
|EQUITY ALERT: Rosen Law Firm Announces Investigation of Sigma-Aldrich Corporation Concerning its Proposed Sale to Merck KGaA|
|SIGMA-ALDRICH SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to Merck KGaA (2014/9/22)|
|EUROPE MARKETS: European Mining Stocks Hurt By China Growth Worries (2014/9/22)|
|European mining stocks hurt by China growth worries (2014/9/22)|
|SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Sigma-Aldrich Corporation And Encourages Investors To Contact The Firm For Additional Information|
Click above to view more mutual fund data and stats for mkgay - Merck KGaA ADR.